Evidence map›Paper›PMID 36426850›Full record

ArticleeLife2022

Cell-intrinsic ceramides determine T cell function during melanoma progression.

Matthias Hose, Anne Günther, Eyad Naser, Fabian Schumacher, Tina Schönberger, Julia Falkenstein, Athanasios Papadamakis, Burkhard Kleuser, Katrin Anne Becker, Erich Gulbins and 4 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. The influence of metabolic disorders on adaptive immunity.Cellular & molecular immunology · 2024
    Review
  14. Article
  15. Poor clinical outcomes and immunoevasive contexture in CD161Journal for immunotherapy of cancer · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Matthias Hose *Institute of Medical Microbiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.ORCID 0000-0003-0746-5591
Anne Günther *Institute of Medical Microbiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Eyad NaserInstitute of Molecular Biology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Fabian SchumacherInstitute of Pharmacy, Freie Universität Berlin, Berlin, Germany.ORCID 0000-0001-8703-3275
Tina SchönbergerInstitute of Physiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Julia FalkensteinInstitute of Medical Microbiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Athanasios PapadamakisInstitute of Medical Microbiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.ORCID 0000-0002-4095-4242
Burkhard KleuserInstitute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
Katrin Anne BeckerInstitute of Molecular Biology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Erich GulbinsInstitute of Molecular Biology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Adriana Haimovitz-FriedmanMemorial Sloan Kettering Cancer Center, New York City, United States.ORCID 0000-0002-4884-0581
Jan BuerInstitute of Medical Microbiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.ORCID 0000-0002-7602-1698
Astrid M WestendorfInstitute of Medical Microbiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.ORCID 0000-0002-2121-2892
Wiebke HansenInstitute of Medical Microbiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.ORCID 0000-0002-6020-0886
University of Duisburg-Essen · DEFreie Universität Berlin · DECzech Academy of Sciences, Institute of Physiology · CZMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Acid sphingomyelinase (Asm) and acid ceramidase (Ac) are parts of the sphingolipid metabolism. Asm hydrolyzes sphingomyelin to ceramide, which is further metabolized to sphingosine by Ac. Ceramide generates ceramide-enriched platforms that are involved in receptor clustering within cellular membranes. However, the impact of cell-intrinsic ceramide on T cell function is not well characterized. By using T cell-specific Asm- or Ac-deficient mice, with reduced or elevated ceramide levels in T cells, we identified ceramide to play a crucial role in T cell function in vitro and in vivo. T cell-specific ablation of Asm in

Indexed as

CeramidesMelanomaAnimalsCD8-Positive T-LymphocytesMiceReceptors, Antigen, T-CellSphingosineCeramidesReceptors, Antigen, T-CellSphingosineceramideimmunologyinflammationmelanomamousesphingolipidsT cells

Identifiers

PMID36426850
PMCPMC9699697
OpenAlexW4310083489

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.